Login / Signup

Shifting research culture to address the mismatch between where trials recruit and where populations with the most disease live: a qualitative study.

Tanvi RaiSharon DixonSue Ziebland
Published in: BMC medical research methodology (2021)
While improvements in equity and capacity building certainly matter to CIs, most are primarily motivated by their commitment to delivering successful trials. Highlighting the benefits to trial delivery is therefore likely to be the best way to encourage CIs to focus their research activity in areas of greatest need.
Keyphrases
  • study protocol
  • clinical trial
  • phase ii
  • public health
  • open label
  • cell fate